Literature DB >> 9042284

Amyloidoma of bone, a plasma cell/plasmacytoid neoplasm. Report of three cases and review of the literature.

S E Pambuccian1, I D Horyd, T Cawte, A G Huvos.   

Abstract

Tumoral amyloidosis (amyloidoma) of bone is a rare condition characterized by the massive destructive deposition of AL amyloid in bones. We report three cases. The patients ranged in age from 45 to 78 years and had tumors located in the lumbar spine, scapula, and humeral head measuring 6.5 to 18 cm. The radiologic diagnosis was chondrosarcoma in two cases. Microscopically, there were large, rounded deposits of amorphous eosinophilic material surrounded by numerous giant cells and a sparse lymphoplasmacytic infiltrate. The deposits proved to be composed of AL amyloid showing potassium permanganate resistant congophilia. Immunohistochemistry showed immunoglobulin IgG lambda, IgG kappa, and IgM lambda monoclonality of the plasma cell and (in one case) lymphoid infiltrate. The tumors were classified by morphology and immunohistochemistry as solitary plasmacytomas of bone (two cases) and plasmacytoid lymphoma (one case). During the relatively short follow-up period, one patient progressed to symptomatic generalized amyloidosis and died, one patient died of recurrent tumor, and one patient is alive with no evidence of disease. An extensive review of the world literature showed 34 well-documented similar cases, occurring most often in the spine and skull, causing neurologic symptoms, tending to occur in middle-aged men and frequently progressing to generalized disease. Most if not all AL amyloidomas of bone represent solitary plasmacytomas of bone or plasmacytoid lymphomas.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9042284     DOI: 10.1097/00000478-199702000-00007

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  8 in total

1.  Amyloidoma of the skull base.

Authors:  W A Simoens; L van den Hauwe; E Van Hedent; F Warson; R Demaeseneer; D Williams; A M De Schepper
Journal:  AJNR Am J Neuroradiol       Date:  2000-09       Impact factor: 3.825

2.  Extramedullary plasmocytoma associated with a massive deposit of amyloid in the duodenum.

Authors:  Fabiana Pirani Carneiro; Maria Nazareth Machado Sobreira; Lívia Bravo Maia; Alesso Cervantes Sartorelli; Luiz Eduardo de Almeida Prado Franceschi; Mauro Brito Brandão; Bárbara Wosnjuk Calaça; Fernando Silva Lustosa; João Vieira Lopes
Journal:  World J Gastroenterol       Date:  2009-07-28       Impact factor: 5.742

3.  Intraosseous calcifying epithelial odontogenic tumor in a case with multiple myeloma.

Authors:  Priya S Shanmuga; A Ravikumar; K Krishnarathnam; S Rajendiran
Journal:  J Oral Maxillofac Pathol       Date:  2009-01

4.  Calcified amyloid tumor of neck with exuberant giant cell reaction.

Authors:  Arghya Bandyopadhyay; Shubham Bhattacharya; Barnali Maiti; Koushik Bose
Journal:  J Lab Physicians       Date:  2015 Jan-Jun

5.  Osteoprotegerin is a significant prognostic factor for overall survival in patients with primary systemic amyloidosis independent of the Mayo staging.

Authors:  E Kastritis; M Gavriatopoulou; M A Dimopoulos; E Eleutherakis-Papaiakovou; N Kanellias; M Roussou; C Pamboucas; S T Toumanidis; E Terpos
Journal:  Blood Cancer J       Date:  2015-06-05       Impact factor: 11.037

6.  Multiple myeloma-associated amyloidoma of the sacrum: case report and review of the literature.

Authors:  F M Klenke; C Wirtz; Y Banz; M J B Keel; N D Klass; U Novak; L M Benneker
Journal:  Global Spine J       Date:  2013-11-22

7.  Long-Term Control of Primary Cerebral ALH Amyloidoma With Focal Radiation Therapy.

Authors:  Jay C Shiao; Andrew B Wolf; Rachel A Rabinovitch; Clay Smith; B K Kleinschmidt-DeMasters; Douglas E Ney
Journal:  Adv Radiat Oncol       Date:  2021-10-21

8.  18F-fluorodeoxyglucose positron emission tomography might be useful for diagnosis of hepatic amyloidosis.

Authors:  Akinobu Tawada; Tatsuo Kanda; Takashi Oide; Toshio Tsuyuguchi; Fumio Imazeki; Yukio Nakatani; Osamu Yokosuka
Journal:  Int Med Case Rep J       Date:  2014-06-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.